Skip to main content
. 2020 Apr 2;19(6):3571–3580. doi: 10.3892/etm.2020.8635

Figure 2.

Figure 2

Migration and invasion of A549 and SK-MES-1 cell lines (). (A) Number of migrating cells was significantly increased after CCL25 treatment and the addition of an anti-CCR9 antibody could significantly abrogate this increase. (B) Number of invading cells was significantly increased after CCL25 treatment and the addition of an anti-CCR9 antibody significantly inhibited this increase. Magnification, x200. *P<0.05. CCR9, CC chemokine receptor 9; CCL25, CC motif chemokine ligand 25; AC, adenocarcinoma; SCC, squamous cell carcinoma.